Blocking HDACs boosts regulatory T cells
Blocking HDACs boosts regulatory T cells | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the
best experience, we recommend you use a more up to date browser (or turn off compatibility
mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying
the site without styles and JavaScript. Advertisement Nature Medicine View all journals
Search My Account Explore content About the journal Publish with us Sign up for alerts RSS …
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the
best experience, we recommend you use a more up to date browser (or turn off compatibility
mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying
the site without styles and JavaScript. Advertisement Nature Medicine View all journals
Search My Account Explore content About the journal Publish with us Sign up for alerts RSS …
Histone deacetylase inhibitors, which are in clinical use as anticancer agents, also affect the biology of regulatory T cells. These inhibitors may also hold promise as immunomodulatory drugs (pages 1299–1307).
nature.com